# Engineered Dendritic Cell Vaccines for Multiple Myeloma

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: Shenzhen Geno-Immune Medical Institute · Condition: Multiple Myeloma or Plasmacytoma

- Company: Shenzhen Geno-Immune Medical Institute
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06435910

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.